Dawna D Allore, RN, Elizabeth A. Koselke, PharmD, Shawna L Kraft, PharmD, BCOP, Emily R Mackler, PharmD, BCOP, Bernard L Marini, PharmD, Suzette C Walker, DNP, FNP-BC, AOCNP
Cancer in women ages 15 to 19 years is relatively rare, but when it occurs, menstruation can result in clinically significant complications. During the care of hematologic malignancies, heavy menstrual bleeding in this patient population is commonly correlated with thrombocytopenia. The effects of chemotherapy, radiation, or bone marrow transplantation are also potential secondary causes of therapy-induced thrombocytopenia, leading to excessive menstrual bleeding.
Results 1 - 4 of 4